EBNA leader protein orchestrates chromatin architecture remodeling during Epstein-Barr virus-induced B cell transformation
Epstein-Barr virus Nuclear Antigen Leader Protein (EBNA-LP) plays a pivotal role in the transformation of B cells by Epstein-Barr virus (EBV), functioning independently of EBNA2 to regulate chromatin architecture and gene expression. Our study reveals that EBNA-LP binds to chromatin regions distinct from EBNA2 and facilitates the formation of long-distance chromatin loops by interacting with the cellular factor YY1. This interaction reconfigures the three-dimensional structure of the host genome, enhancing the integrity of topologically associating domains (TADs) and promoting the interaction between enhancers and promoters within these domains. In EBV-infected B cells, EBNA-LP strengthens YY1-mediated chromatin loops within TADs, which helps maintain stable regulatory programs essential for B cell transformation. Notably, EBNA-LP is crucial for establishing EBV-induced enhancers, yet it is not required for their maintenance once formed. Additionally, our data suggest a compensatory increase in CTCF binding in the absence of EBNA-LP, leading to more promiscuous chromatin interactions between TADs and a reduced TAD insulation at their boundaries. These findings provide new insights into the molecular mechanisms by which EBV reshapes the host genome chromatin architecture to support B cell transformation and highlight potential therapeutic targets for disrupting EBV-driven oncogenesis.
Authors
- Lisa Beatrice Caruso (ORCID: https://orcid.org/0000-0003-4248-0551)
- Italo Tempera (ORCID: https://orcid.org/0000-0001-7893-2914)
- Robert E. White (ORCID: https://orcid.org/0000-0002-5115-2173)
- Rachel Sklutuis
- Micah A. Luftig (ORCID: https://orcid.org/0000-0002-2964-1907)
- Davide Maestri
- Jana M. Cable (ORCID: https://orcid.org/0000-0001-9267-611X)
- Sarah Preston‐Alp (ORCID: https://orcid.org/0000-0001-6807-2244)
Institutions
- The Wistar Institute (US)
- Duke University (US)
- Imperial College London (GB)
Publication Details
- Journal
- Nucleic Acids Research
- Published
- 2025-06-20
- DOI
- https://doi.org/10.1093/nar/gkaf629
- Citations
- 3
- Primary Topic
- Viral-associated cancers and disorders
- Type
- article
- Field-Weighted Citation Impact
- 3.14
Funders
- National Institutes of Health